Search

Your search keyword '"Schoemaker, Minouk J."' showing total 126 results

Search Constraints

Start Over You searched for: Author "Schoemaker, Minouk J." Remove constraint Author: "Schoemaker, Minouk J." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
126 results on '"Schoemaker, Minouk J."'

Search Results

1. Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

2. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

3. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

4. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

5. Hypertensive conditions of pregnancy, preterm birth, and premenopausal breast cancer risk: a premenopausal breast cancer collaborative group analysis

6. BMI and breast cancer risk around age at menopause

7. Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women

8. Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts

9. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

10. Real-World Treatment Patterns and Survival Outcomes for Patients with Non-Metastatic Non-Small-Cell Lung Cancer in Sweden: A Nationwide Registry Analysis from the I-O Optimise Initiative

11. BMI and breast cancer risk around age at menopause

12. Real-World Treatment Patterns and Survival Outcomes for Patients with Non-Metastatic Non-Small-Cell Lung Cancer in Sweden: A Nationwide Registry Analysis from the I-O Optimise Initiative

13. International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts

14. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry

15. Cancer incidence and mortality in 23 000 patients with type 1 diabetes in the UK: Long‐term follow‐up

16. Supplementary Methods, Figures S1 - S3 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

17. Supplementary Tables S1 - S10 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

18. Supplementary Acknowledgments from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

19. Data from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

20. Supplementary Grant Support from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

21. Supplementary Table 1 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

22. Supplementary Table 7 from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma

23. Supplementary Tables and References from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

24. Supplementary Table 2 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

25. Supplementary Figure 1 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

26. Supplementary Figure 2 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

27. Supplementary Figure 3 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

28. Data from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma

29. Supplementary Figure Legends from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

30. Supplementary Figure 4 from Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study

31. Supplementary Table 6 from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma

32. Data from The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium

33. Supplementary Table 5 from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma

34. Table S1 from The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium

35. Supplementary Data from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma

36. Data from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

37. Supplementary Figures from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

38. Data from 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus

39. Supplementary Tables 1-13 from 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus

40. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

41. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

42. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women

43. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women

44. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women

45. Additional file 4 of Common variants in breast cancer risk loci predispose to distinct tumor subtypes

46. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas

48. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

49. Gestational diabetes and risk of breast cancer before age 55 years.

50. Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women.

Catalog

Books, media, physical & digital resources